174 related articles for article (PubMed ID: 33361738)
1. Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid Carcinoma.
Ghazani AA; Breen KM; Dwan M; Barletta JA; Vatnick DR; Stokes SM; Block C; Doherty GM; Cohn AY; Marqusee E; Garber JE; Rana HQ
Am J Case Rep; 2020 Dec; 21():e927415. PubMed ID: 33361738
[TBL] [Abstract][Full Text] [Related]
2. A Case of medullary thyroid carcinoma with de novo V804M RET germline mutation.
Choi YS; Kwon HJ; Kim BK; Kwon SK; Park YH; Kim JH; Jung SB; Lee CH; Lee SK; Uchino S
J Korean Med Sci; 2013 Jan; 28(1):156-9. PubMed ID: 23341727
[TBL] [Abstract][Full Text] [Related]
3. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
[TBL] [Abstract][Full Text] [Related]
4. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
[TBL] [Abstract][Full Text] [Related]
5. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
6. Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.
Basaran MN; Tuna MM; Karakılıç E; Doğan BA; İmga NN; Berker D; Güler S
J Endocrinol Invest; 2015 May; 38(5):541-6. PubMed ID: 25501606
[TBL] [Abstract][Full Text] [Related]
7. Medullary Thyroid Carcinoma Associated with Germline RET
Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
[TBL] [Abstract][Full Text] [Related]
8. p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer.
Loveday C; Josephs K; Chubb D; Gunning A; Izatt L; Tischkowitz M; Ellard S; Turnbull C
J Clin Endocrinol Metab; 2018 Nov; 103(11):4275-4282. PubMed ID: 29590403
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.
Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N
J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779
[TBL] [Abstract][Full Text] [Related]
10.
Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ
Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476
[No Abstract] [Full Text] [Related]
11. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
[TBL] [Abstract][Full Text] [Related]
12. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
13. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
[TBL] [Abstract][Full Text] [Related]
14. Child with RET proto-oncogene codon 634 mutation.
İnce D; Demirağ B; Ataseven E; Oymak Y; Tuhan H; Karakuş OZ; Hazan F; Abacı A; Özer E; Mutafoglu K; Olgun N
Turk J Pediatr; 2017; 59(5):590-593. PubMed ID: 29745123
[TBL] [Abstract][Full Text] [Related]
15. Controversy on the management of patients carrying RET p.V804M mutation.
Alzahrani AS; Alswailem M; Alghamdi B; Rafiullah R; Aldawish M; Al-Hindi H
Endocrine; 2022 Feb; 75(2):478-486. PubMed ID: 34637071
[TBL] [Abstract][Full Text] [Related]
16. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
17. Role of preoperative basal calcitonin levels in the timing of prophylactic thyroidectomy in patients with germline RET mutations.
Lifante JC; Blanchard C; Mirallié E; David A; Peix JL
World J Surg; 2014 Mar; 38(3):576-81. PubMed ID: 24357249
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
19. V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers.
Lecube A; Hernandez C; Oriola J; Galard R; Gémar E; Mesa J; Simó R
Surgery; 2002 May; 131(5):509-14. PubMed ID: 12019403
[TBL] [Abstract][Full Text] [Related]
20. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
